6021 - 6030 of 6230 Results
Title
Year
- Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson’s disease and pharmacodynamic biomarkers2023OPENTitle: Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson’s disease and pharmacodynamic biomarkersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00445-9Best OA location URL: https://www.nature.com/articles/s41531-023-00445-9.pdfCitation Count: 17
- The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain2019OPENTitle: The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrainJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 323Issue #:Start Page: 113062End Page: 113062Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.113062Best OA location URL: https://opus.lib.uts.edu.au/bitstream/10453/136564/4/Binder1.pdfCitation Count: 14
- Understanding the Neurobiology of Cd200 and the Cd200 Receptor: A Therapeutic Target For Controlling Inflammation In Human Brains?2013OPENTitle: Understanding the Neurobiology of Cd200 and the Cd200 Receptor: A Therapeutic Target For Controlling Inflammation In Human Brains?Journal Name: Future NeurologyPublisher: Informa UK LimitedVol: 8Issue #: 3Start Page: 321End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/fnl.13.14Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3815586Citation Count: 50
- Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils2023OPENTitle: Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau ProtofibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 18Start Page: 3528End Page: 3539Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00437Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.3c00437Citation Count: 16
- Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson’s disease2023OPENTitle: Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00555-4Best OA location URL: https://www.nature.com/articles/s41531-023-00555-4.pdfCitation Count: 16
- Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus2018OPENTitle: Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human HerpesvirusJournal Name: NeuronPublisher: Elsevier BVVol: 99Issue #: 1Start Page: 64End Page: 82.e7Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2018.05.023Best OA location URL: http://www.cell.com/article/S0896627318304215/pdfCitation Count: 645
-
OPENTitle: Aging, Parkinson’s Disease, and Models: What Are the Challenges?Journal Name: Aging BiologyPublisher: Aging Biology LLCVol: 1Issue #: 1Start Page: 20230010End Page: 20230010Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.59368/agingbio.20230010Best OA location URL: https://agingcelljournal.org/Archive/Volume3/ageing_parkinsons_disease_and_models/agingbio.20230010.pdfCitation Count: 4
- Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease2021OPENTitle: Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00182-xBest OA location URL: https://www.nature.com/articles/s41531-021-00182-x.pdfCitation Count: 27
-
OPENTitle: PKA-RII subunit phosphorylation precedes activation by cAMP and regulates activity terminationJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 217Issue #: 6Start Page: 2167End Page: 2184Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1083/jcb.201708053Best OA location URL: https://rupress.org/jcb/article-pdf/217/6/2167/1067112/jcb_201708053.pdfCitation Count: 49
- The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss2019OPENTitle: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6592621Citation Count: 12